Acute Myeloid Leukemia (AML)

Dr. David Sallman is an Assistant Member in the Department of Malignant Hematology at Moffitt Cancer Center. Dr. Sallman’s clinical interests are myelodysplastic syndromes (MDS), acute myeloid leukemia (AML) and myeloproliferative neoplasms (MPN). Dr. Sallman earned his MD degree from the University of South Florida College of Medicine. He completed an Internal Medicine Residency at Massachusetts General Hospital and, most recently, a Hematology/Oncology Fellowship at Moffitt Cancer Center. His research interests focus on the development of novel, targeted therapeutic strategies (Phase I and

Dr. Rampal is a hematology-oncology physician who specializes in the treatment of myeloproliferative neoplasms (MPN) and leukemia. He is dedicated to providing my patients with the best possible care, taking into account the individual needs of each patient and his or her family. In addition, Dr. Rampal is an active researcher whose focus is the development of new and innovative approaches to treating MPNs and leukemia. He is working to understand the genetic events that contribute to the development and progression of leukemia and MPNs in the hope of developing new targeted therapies for

Dr. Patel is an Assistant Professor at the University of Nebraska Medical Center. His reasearch interests include: Hematopoietic stem cell transplantation; alternative donors transplant including umbilical cord blood, transplantation of malignant and non-malignant disease.

Dr. Ron Paquette is a member of the Blood and Marrow Transplant Program at Cedars-Sinai. He is a physician and researcher who treats patients with hematologic disorders including aplastic anemia, myelodysplastic syndrome, leukemias and lymphomas. He attended medical school at The Ohio State University, completed his Internal Medicine residency and Hematology-Oncology fellowship at the University of California, Los Angeles. He was previously a faculty member at UCLA before joining Cedars-Sinai Medical Center.

Dr. Olson's clinical efforts focus on pediatric hematopoietic stem cell transplantation (HSCT), with a specific emphasis on HSCT for patients with inherited and acquired bone marrow failure. Through his combined clinical activities in the Bone Marrow Failure Center within the Division of Hematology and the Blood and Marrow Transplant Section within the Division of Oncology, his goal is to facilitate outstanding care for patients with inherited bone marrow failure and acquired aplastic anemia during their transition from diagnostic evaluation to treatment through HSCT. In coordination with